Leroy Hood

McCarthy, Kelly
September 2000
Directors & Boards;Fall2000, Vol. 25 Issue 1, p58
Trade Publication
Profiles Lynx Therapeutics board director Leroy Hood. Background in biotechnology; Career history; Views on business and science.


Related Articles

  • Renowned scientist to speak here this fall. Hatch, Addy // Journal of Business (10756124);7/3/2003, Vol. 18 Issue 14, pA3 

    Announces that biotechnology scientist Leroy Hood has been slated to speak at the Spokane Regional Chamber of Commerce's annual meeting on September 30, 2003, in Washington. Hood's professional accomplishments; Career history; Reasons of the chamber for choosing Hood to speak at the event.

  • BASF invests $66 million in venture with U.S. firm. Rotman, David // Chemical Week;10/30/1996, Vol. 158 Issue 41, p18 

    Reports on BASF's agreement to form a joint venture with biotechnology firm Lynx Therapeutics of Hayward, California. BASF's investment in the new company to be called BASF-Lynx Bioscience; Lynx's development of gene sequencing technology that could simultaneously analyze the activity of all the...

  • Universities, capital, locale keys to biotech. Hatch, Addy // Journal of Business (10756124);7/31/2003, Vol. 18 Issue 16, pA15 

    Reports on the views of scientist Leroy Hood on the potential of biotechnology industry in Spokane, Washington. Key elements in building a biotechnology industry; Strengths and weaknesses of Spokane for building a biotechnology industry.

  • Lynx Announces SNP Colaboration With Oxagen.  // Worldwide Biotech;Jul99, Vol. 11 Issue 7, p5 

    Reports that Lynx Therapeutics Inc. signed an agreement with Oxagen Limited regarding a program on the discovery and validation of disease-associated single nucleotide polymorphisms (SNP). Initial focus of the program; Separate tasks of Lynx and Oxagen; Designed uses of Lynx's SNP technologies;...

  • Lynx Launches Comparative Transciptome Study. Holland-Moritz, Pam // Genomics & Proteomics;May2003, Vol. 3 Issue 4, p15 

    Reports on Lynx Therapeutics Inc.'s agreement for a comparative transcriptome study with the Genome Institute of Singapore at the National University of Singapore. Application of Lynx's Massively Parallel Signature Sequencing technology to generate comprehensive gene expression profiles.

  • The Value of MPSS.  // Drug Discovery & Development;Jun2002, Vol. 5 Issue 6, p79 

    Discusses the value of massively parallel signature sequencing (MPSS) as a genomics technique for analyzing the expression of genes in a sample. MPSS as open-ended platform that counts the number of individual mRNA molecules produced from each gene; Systems biology experiments conducted by Lynx...

  • Approaching Science With a System. Janssen, Deborah // Genomics & Proteomics;Jan/Feb2002, Vol. 2 Issue 1, p22 

    Features the scientific contributions of the Institute for Systems Biology in Seattle. History of the organization; Establishment of the organization by scientist Leroy Hood; Names of the pioneers of the organization. INSETS: Why Sea Urchins?;The Future Leroy Hoods of the World.

  • The Pied Piper of SCIENCE. Kuzma, Cindy // Science & Spirit;Jan/Feb2004, Vol. 15 Issue 1, p26 

    Profiles biologist Leroy Hood. Education; Family; Contributions to the development of proteomics; Hopes to transform biology into a field that recognizes both simplicity and intricacy; Invention of the DNA sequences; View that scientists that a responsibility to give lessons to children. ...

  • A New Vision. Helm, Leslie // Seattle Business;Jan2012, Vol. 23 Issue 1, p8 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the 1962 World's Fair, Institute for Systems Biology founder Leroy Hood and the Institute for Health Metrics and Evaluation's (IHME) efforts towards public health enlightenment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics